Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
NLS Pharma Stock Gains As Its Narcolepsy Candidate To Enter Mid-Stage Study Next Month
New Study Data Confirms NLS Pharmaceutics' Mazindol Orexin Pathway Activation For Sleeping Disorder
Avadel's Formulated Sodium Oxybate Shows Improved Sleepiness, Sleep Quality In Narcolepsy Patients